Retatrutide Phase 3 Results: What People With Type 2 Diabetes Should Know 10th June 2026 by Living Diabetes Editorial Phase 3 retatrutide data in recent-onset type 2 diabetes showed A1C lowering and weight loss. The drug remains investigational and is not FDA-approved.
Metformin: Benefits, Side Effects, and Safety Questions 6th June 202631st January 2023 by Living Diabetes Editorial Metformin is a common type 2 diabetes medicine. Learn how it works, common side effects, kidney checks, and safety questions.
